Accessibility StatementSkip Navigation NEW YORK, Nov. 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in James Hardie Industries plc. ("James Hardie Industries plc." or the "Company") (NYSE: JHX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of James Hardie Industries plc. investors who were adversely affected by alleged securities fraud between May 20, 2025 and August 18, 2025. Follow the link below to get more information and be con ...

Core Viewpoint - A class action securities lawsuit has been filed against Inspire Medical Systems, Inc. due to alleged securities fraud affecting investors between August 6, 2024, and August 4, 2025 [2][4]. Group 1: Lawsuit Details - The lawsuit claims that the launch of Inspire Medical's new product, Inspire V, was unsuccessful due to poor demand and excess inventory at treatment centers, contradicting the company's assurances of a successful launch [3]. - Defendants allegedly failed to complete essential tasks for the product launch, including training for treatment center customers, setting up IT systems, and ensuring proper Medicare reimbursement [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until January 5, 2026, to request appointment as lead plaintiff, although participation does not require this role [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the U.S. [5].

Accessibility StatementSkip Navigation NEW YORK, Nov. 7, 2025 /PRNewswire/ --Â Levi & Korsinsky, LLP notifies investors in James Hardie Industries plc. ("James Hardie Industries plc." or the "Company") (NYSE: JHX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of James Hardie Industries plc. investors who were adversely affected by alleged securities fraud between May 20, 2025 and August 18, 2025. Follow the link below to get more information and be con ...

Core Viewpoint - A class action securities lawsuit has been filed against James Hardie Industries plc, alleging securities fraud that negatively impacted investors between May 20, 2025, and August 18, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors affected by alleged securities fraud during the specified period [2]. - The complaint claims that the defendants made false statements and concealed adverse facts regarding the North America segment of James Hardie, including deteriorating consumer demand and excessive inventory at distributors [3]. Group 2: Investor Information - Investors who suffered losses during the relevant timeframe have until December 23, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [5].

NEW YORK, Oct. 31, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lantheus investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 5, 2025. Follow the link below to get more information and be contacted by a member of our team: Accessibility StatementSkip Navigation https: ...

Core Viewpoint - aTyr Pharma, Inc. is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between January 16, 2025, and September 12, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit claims that aTyr provided misleading statements regarding the efficacy of its drug Efzofitimod, particularly its ability to allow patients to taper steroid usage completely [2] - The truth about the drug's efficacy was revealed on September 15, 2025, when aTyr announced that the EFZO-FIT study did not meet its primary endpoint, specifically regarding the change from baseline in mean daily OSC dose at week 48 [2] - Following the announcement, aTyr's stock price plummeted from $6.03 per share on September 12, 2025, to $1.02 per share on September 15, 2025, marking a decline of 83.2% in just one day [2] Group 2: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until December 8, 2025, to request the Court to appoint them as lead plaintiff [3] - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4]

NEW YORK , Oct. 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in WPP plc ("WPP" or the "Company") (NYSE: WPP) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of WPP investors who were adversely affected by alleged securities fraud between February 27, 2025 and July 8, 2025. ...

Accessibility StatementSkip Navigation NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Levi &Â Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Semler Scientific, Inc. investors who were adversely affected by alleged securities fraud between March 10, 2021 and April 15, 2025. Follow the link below to get more information and be contacted by ...

Core Viewpoint - A class action securities lawsuit has been filed against RCI Hospitality Holdings, Inc. alleging securities fraud affecting investors between December 15, 2021, and September 16, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that the defendants engaged in tax fraud and bribery to conceal this fraud, leading to an understatement of the legal risks faced by the company [3]. - It is alleged that the defendants' statements regarding the company's business, operations, and prospects were materially false and misleading [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until November 20, 2025, to request to be appointed as lead plaintiff, although participation does not require this role [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [5].

Core Viewpoint - A class action securities lawsuit has been filed against Charter Communications, Inc. alleging securities fraud affecting investors during a specific time frame [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors who purchased or acquired Charter securities or options between July 26, 2024, and July 24, 2025 [2]. - The complaint alleges that the company made false statements regarding the impact of the Affordable Connectivity Program (ACP) ending, which was not managed effectively by the company [3]. - It is claimed that the end of the ACP had a significant negative impact on internet customer declines and revenue, which the company failed to address adequately [3]. Group 2: Company Performance and Misrepresentation - The lawsuit asserts that Charter's execution strategy did not compensate for the adverse effects of the ACP ending, leading to greater risks to business plans and earnings growth than reported [3]. - The company allegedly lacked a reasonable basis for its positive statements about business operations and long-term growth, misleading investors during the class period [3]. Group 3: Next Steps for Investors - Investors who suffered losses during the relevant time frame have until October 14, 2025, to request appointment as lead plaintiff, although participation does not require this role [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 4: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [5].